MoneyWorks4Me

Zydus Lifesciences informs about post results conference call

16 May 2022 Evaluate

Zydus Lifesciences has informed that the financial results of the company for Q4 2021-22 (January-March 2022) would be declared on May 20, 2022. Post results Q&A session through webinar (powered by Zoom) has been scheduled on the same day- May 20, 2022 at 5:00 pm. Sharvil Patel, Managing Director of the Company would be hosting the call and the details to join the call is provided in the attached file.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1105.00 -12.00 (-1.07%)
19-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1898.00
Dr. Reddys Labs. 1171.00
Cipla 1416.00
Lupin 2220.00
Zydus Lifesciences 1105.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: